Richard Lo
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
-
- Renal cell carcinoma treatment 1
- Co-authors
- Jin‐Yao Teo (1 shared paper)Pierce K. H. Chow (1 shared paper)Farah Gillian Irani (1 shared paper)John Carson Allen (1 shared paper)Guili Zhu (1 shared paper)Brian Kim-Poh Goh (1 shared paper)David Chee‐Eng Ng (1 shared paper)Mark Christiaan Burgmans (1 shared paper)
In The Last Decade
Richard Lo
8 papers receiving 699 citations
Richard Lo's Hit Papers
Peers
Comparison fields: 5 of 35
- Hepatology 632
- Epidemiology 168
- Pathology and Forensic Medicine 85
- Oncology 96
- Pulmonary and Respiratory Medicine 109
Countries citing papers authored by Richard Lo
This map shows the geographic impact of Richard Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Lo more than expected).
Fields of papers citing papers by Richard Lo
This network shows the impact of papers produced by Richard Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Lo. The network helps show where Richard Lo may publish in the future.
Co-authors
The 21 scholars most cited alongside Richard Lo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma Hit paper breakdown → | 2018 | 523 |
| 2 | 2021 | 109 | |
| 3 | 2014 | 39 | |
| 4 | 2013 | 30 | |
| 5 | 2009 | 4 | |
| 6 | 2024 | 4 | |
| 7 | 2016 | 3 | |
| 8 | 2025 | 2 |
About Richard Lo
Richard Lo is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Surgery, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 714 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pediatric Urology and Nephrology Studies (1 paper), Peripheral Nerve Disorders (1 paper), Peripheral Artery Disease Management (1 paper), Renal and related cancers (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Renal cell carcinoma treatment (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Hepatology (632 citations), Epidemiology (168 citations), Pathology and Forensic Medicine (85 citations), Oncology (96 citations) and Pulmonary and Respiratory Medicine (109 citations). Richard Lo has collaborated with scholars based in Singapore, Australia and Hong Kong. Frequent co-authors include Jin‐Yao Teo, Pierce K. H. Chow, Farah Gillian Irani, John Carson Allen, Guili Zhu, Brian Kim-Poh Goh, David Chee‐Eng Ng, Mark Christiaan Burgmans, Kiang‐Hiong Tay and Sunita Chauhan. Their work appears in journals such as The Lancet. Gastroenterology & hepatology, Hepatology International, Journal of Clinical Oncology, World Journal of Surgery and Ultrasound in Medicine & Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.